Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeAmbuAmbu and Medical Advisory Fuel Medical Group Announce Partnership

Ambu and Medical Advisory Fuel Medical Group Announce Partnership

June 30, 2020

Ambu Inc., a rapidly growing pioneer of sterile, single-use medical devices, and Fuel Medical Group, the leading business advisory resource for ENTs, audiologists, otologists, and universities, have entered into a partnership the companies announced today.

Under the agreement, Ambu will offer Fuel Medical entrée to a broad hospital market for services, including marketing, finance, digital strategies, professional development, and recruiting as well as advising practices on maximizing revenue and streamlining administrative operations.

In turn, Fuel Medical, which is based in Camas, Washington, will broaden Ambu’s reach into medical practices by offering an array of state-of-the-art, single-use endoscopes that include rhinolaryngoscopes, bronchoscopes, duodenoscopes, and advanced monitors that increase safety and efficiency.

“This is a perfect match that will enable both companies to expand their reach into new and growing markets,” said Juan Jose Gonzalez, CEO of Ambu A/S. “Fuel Medical has such a strong reputation as a leader in a business advisory that it was difficult to overlook their success. We are thrilled with the partnership and see an incredibly productive future.”

“We couldn’t be more excited about this partnership as we both believe in each other’s missions,” added Brendan Ford, Fuel Medical Group’s Co-Founder. “We have a lot of overlap in our goals, specifically when it comes to innovative ideas and building lasting relationships with our customers.”

Shawn Parker, Fuel Medical Group’s Co-Founder, said “Single-use scopes are ideal for ENT practices as they provide tremendous value due to their sanitary nature. If we can offer safer products to our members, we can help them provide exceptional care to their patients.”

Specifics about the deal were not disclosed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy